CellaVision AB (publ) (STO: CEVI)
Sweden
· Delayed Price · Currency is SEK 218.50
-5.50 (-2.46%)
Nov 29, 2024, 5:29 PM CET
CellaVision AB Revenue
CellaVision AB had revenue of 178.66M SEK in the quarter ending September 30, 2024, with 6.41% growth. This brings the company's revenue in the last twelve months to 737.16M, up 17.20% year-over-year. In the year 2023, CellaVision AB had annual revenue of 677.29M with 5.94% growth.
Revenue (ttm)
737.16M
Revenue Growth
+17.20%
P/S Ratio
6.92
Revenue / Employee
3.23M
Employees
228
Market Cap
5.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 677.29M | 37.95M | 5.94% |
| Dec 31, 2022 | 639.34M | 73.79M | 13.05% |
| Dec 31, 2021 | 565.55M | 94.11M | 19.96% |
| Dec 31, 2020 | 471.44M | 9.67M | 2.09% |
| Dec 31, 2019 | 461.77M | 96.96M | 26.58% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 17.72B |
CellaVision AB News
- 5 weeks ago - Q3 2024 CellaVision AB Earnings Call Transcript - GuruFocus
- 4 years ago - 3 Scandinavian Companies With Strong Margin Growth - GuruFocus